Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing
The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459